158 related articles for article (PubMed ID: 36468287)
1. Survey of recurrent diagnostic challenges in breast phyllodes tumours.
Tan BY; Fox SB; Lakhani SR; Tan PH
Histopathology; 2023 Jan; 82(1):95-105. PubMed ID: 36468287
[TBL] [Abstract][Full Text] [Related]
2. Refining the classification of breast phyllodes tumours.
Tan PH
Pathology; 2023 Jun; 55(4):437-448. PubMed ID: 37085395
[TBL] [Abstract][Full Text] [Related]
3. Core needle biopsy diagnosis of fibroepithelial lesions of the breast: a diagnostic challenge.
Li JJX; Tse GM
Pathology; 2020 Oct; 52(6):627-634. PubMed ID: 32771211
[TBL] [Abstract][Full Text] [Related]
4. Role of CD10 Immunoexpression in Grading Phyllodes Tumour of the Breast.
Kulkarni MM; Khandeparkar SG; Joshi AR; Kothikar V; Nasare A; Patil S; Niraspatil S; Dhande B
J Clin Diagn Res; 2017 Jan; 11(1):EC14-EC16. PubMed ID: 28273972
[TBL] [Abstract][Full Text] [Related]
5. Fibroepithelial lesions revisited: implications for diagnosis and management.
Tan PH
Mod Pathol; 2021 Jan; 34(Suppl 1):15-37. PubMed ID: 32461622
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic stromal histomorphology in fibroepithelial breast lesions: a fresh perspective.
Aiyer HM; Jain M; Thomas S; Logani KB
Indian J Pathol Microbiol; 2000 Jan; 43(1):5-12. PubMed ID: 12583412
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in phyllodes tumours of the breast: retrospective study on 166 consecutive cases.
Di Liso E; Bottosso M; Lo Mele M; Tsvetkova V; Dieci MV; Miglietta F; Falci C; Faggioni G; Tasca G; Giorgi CA; Giarratano T; Mioranza E; Michieletto S; Saibene T; Dei Tos AP; Conte P; Guarneri V
ESMO Open; 2020 Oct; 5(5):e000843. PubMed ID: 33020219
[TBL] [Abstract][Full Text] [Related]
8. Fibroepithelial tumours of the breast-a review.
Lerwill MF; Lee AHS; Tan PH
Virchows Arch; 2022 Jan; 480(1):45-63. PubMed ID: 34505197
[TBL] [Abstract][Full Text] [Related]
9. Distinction of phyllodes tumor from fibroadenoma: a reappraisal of an old problem.
Krishnamurthy S; Ashfaq R; Shin HJ; Sneige N
Cancer; 2000 Dec; 90(6):342-9. PubMed ID: 11156517
[TBL] [Abstract][Full Text] [Related]
10. Radiologic-Pathologic Correlation of Fibroepithelial Lesions: A Pictorial Review.
Zhang M; Compton L; Hwang H; Hayes JC
J Breast Imaging; 2022 Oct; 4(5):513-519. PubMed ID: 38416944
[TBL] [Abstract][Full Text] [Related]
11. Collagen type III α1 as a useful diagnostic immunohistochemical marker for fibroepithelial lesions of the breast.
Wang Y; Resnick MB; Lu S; Hui Y; Brodsky AS; Yang D; Yakirevich E; Wang L
Hum Pathol; 2016 Nov; 57():176-181. PubMed ID: 27498063
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic concordance of phyllodes tumour of the breast.
Rakha E; Mihai R; Abbas A; Bennett R; Campora M; Morena P; Toss M; Ellis I
Histopathology; 2021 Oct; 79(4):607-618. PubMed ID: 33966296
[TBL] [Abstract][Full Text] [Related]
13. Interobserver variation in the diagnosis of fibroepithelial lesions of the breast: a multicentre audit by digital pathology.
Dessauvagie BF; Lee AHS; Meehan K; Nijhawan A; Tan PH; Thomas J; Tie B; Treanor D; Umar S; Hanby AM; Millican-Slater R
J Clin Pathol; 2018 Aug; 71(8):672-679. PubMed ID: 29440134
[TBL] [Abstract][Full Text] [Related]
14. Fibroadenoma versus phyllodes tumor: a vexing problem revisited!
Tummidi S; Kothari K; Agnihotri M; Naik L; Sood P
BMC Cancer; 2020 Jul; 20(1):648. PubMed ID: 32660435
[TBL] [Abstract][Full Text] [Related]
15. Can problematic fibroepithelial lesions be accurately classified on core needle biopsies?
Bandyopadhyay S; Barak S; Hayek K; Thomas S; Saeed H; Beydoun R; Shi D; Arabi H; Ruterbusch J; Cote M; Ali-Fehmi R
Hum Pathol; 2016 Jan; 47(1):38-44. PubMed ID: 26521710
[TBL] [Abstract][Full Text] [Related]
16. Predicting clinical behaviour of breast phyllodes tumours: a nomogram based on histological criteria and surgical margins.
Tan PH; Thike AA; Tan WJ; Thu MM; Busmanis I; Li H; Chay WY; Tan MH;
J Clin Pathol; 2012 Jan; 65(1):69-76. PubMed ID: 22049216
[TBL] [Abstract][Full Text] [Related]
17. Phyllodes tumors of the breast: clinicopathological analysis of 106 cases from a single institution.
Efared B; Ebang GA; Tahiri L; Sidibé IS; Erregad F; Hammas N; Melhouf MA; Banani A; Chbani L; Fatemi HE
Breast Dis; 2018; 37(3):139-145. PubMed ID: 29332027
[TBL] [Abstract][Full Text] [Related]
18. In phyllodes tumour of the breast expression of c-kit but not of ALDH1A1 is associated with adverse clinico-pathological features.
Chougule A; Bal A; Das A; Kohli PS; Singh G
Virchows Arch; 2016 Dec; 469(6):651-658. PubMed ID: 27696244
[TBL] [Abstract][Full Text] [Related]
19. Phyllodes tumours of the breast - differentiating features in core needle biopsy.
Tsang AK; Chan SK; Lam CC; Lui PC; Chau HH; Tan PH; Tse GM
Histopathology; 2011 Oct; 59(4):600-8. PubMed ID: 21916949
[TBL] [Abstract][Full Text] [Related]
20. Trends in the Diagnosis of Phyllodes Tumors and Fibroadenomas Before and After Release of WHO Classification Standards.
Chang J; Denham L; Dong EK; Malek K; Lum SS
Ann Surg Oncol; 2018 Oct; 25(10):3088-3095. PubMed ID: 29987607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]